Focusing on rare dyslipidemia, building a patient support network-HoFH/FCS Patient Advocacy Workshop was successfully held in Beijing·Preface ·On September 18-19, 2026, the "2026 China HoFH Patient...

· 24 September：FH Awareness Day  ·Familial hypercholesterolemia (FH) is an autosomal inherited disease caused by a mutation in one of the key genes involved in the catabolism of low-density lipopro...

On September 18, 2026, the "2026 China HoFH Patient Survival Status Survey Report," initiated by Hongmili Mutual Aid Home and jointly completed with the team of Director Zhuang Tian  of the Departm...

The Launch Event for the "2026 China HoFH Patient Survival Status Survey Report" was successfully held in Beijing! With real data as a bridge,Let the plight of 122 families be seenOn September 18,2...

The fund plans to support the  10 projects, including 4 in basic research, 5 in clinical and epidemiological research, and 1 in advanced therapy development.

Delayed diagnosis is a common challenge faced by patients with homozygous familial hypercholesterolemia (HoFH). Due to the rarity of the disease, limited awareness at the primary healthcare level, ...